Last reviewed · How we verify
13-valent pneumococcal vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
13-valent pneumococcal vaccine (13-valent pneumococcal vaccine) — Pfizer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 13-valent pneumococcal vaccine TARGET | 13-valent pneumococcal vaccine | Pfizer | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 13-valent pneumococcal vaccine CI watch — RSS
- 13-valent pneumococcal vaccine CI watch — Atom
- 13-valent pneumococcal vaccine CI watch — JSON
- 13-valent pneumococcal vaccine alone — RSS
Cite this brief
Drug Landscape (2026). 13-valent pneumococcal vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/13-valent-pneumococcal-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab